What happened
Pharmicell disclosed a supply contract with Doosan, worth US$5.55M, about 6.92% of its recent annual revenue, running through Oct 2026.
For context, this single contract equals about 6.92% of the company's most recent annual revenue.
| Counterparty | Doosan |
|---|---|
| Contract value | US$5.55M |
| vs. recent revenue | 6.92% |
| Through | Oct 2026 (from Aug 2026) |
| Filed | 2026-08-07, Supply contract signed |
| Source | DART rcept 20260807800073 → open original filing |
Source: DART. Information only, not investment advice.